About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Nimotuzumab in Combination with Chemoradiotherapy in a Case of Locally Advanced Oesophageal Malignancy

cialis online

cialis generico prezzo deploymentshare.com
J B Sharma
Consultant Medical Oncologist, Action Cancer Hospital, A - 4, Paschim Vihar, New Delhi - 110063, India.
Corresponding Author:
Dr. JB Sharma
Email: drjbsharma7@gmail.com
Received: 17-MAR-2015 Accepted: 26-MAY-2015 Published Online: 15-JUL-2016
DOI: http://dx.doi.org/10.17659/01.2016.0077
Abstract
The cases of esophageal cancer are rapidly increasing worldwide and the highest rates found in Southern and Eastern Africa and Eastern Asia. The treatment option for esophageal cancer is either surgical or non-surgical. We report a 70 year old obese female without any concomitant disease diagnosed with locally advanced esophageal carcinoma with metastasis (T4N1M0). Patient was treated with concurrent chemoradiation along with nimotuzumab 200 mg. The chemotherapy was with cisplatin in the dose of 35 mg/m2 weekly for a period of seven cycles and radiotherapy was with a total radiation dose of 59.5 Gy. The patient responded well to the combination therapy by showing a near absence of tumor lesion, which was evident on a repeat, post treatment whole body PET-CT Scan. Patient tolerated the therapy well without any significant adverse effects. Nimotuzumab was found effective with chemoradiotherapy in treatment of esophageal squamous cell carcinoma.
Keywords : Oesophageal Neoplasms, Squamous Cell Carcinoma, Nimotuzumab, Cisplatin, Chemoradiotherapy.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share